Is Celestica The Best AI Stock to Buy Now?
Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…
Buy
78
LNMG Quote, Financials, Valuation and Earnings
Last price:
$0.0350
Seasonality move
:
614.68%
Day range:
$0.0350 - $0.0350
52-week range:
$0.0028 - $0.0619
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
1.95x
P/B ratio:
0.00x
Volume:
5K
Avg. volume:
5.3K
1-year change:
-43.46%
Market cap:
$121.6K
Revenue:
$13M
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LNMG
Linike Medical Group Ltd.
|
-- | -- | -- | -- | -- |
|
ABT
Abbott Laboratories
|
$11.8B | $1.49 | 6.14% | 54.88% | $133.39 |
|
ARAY
Accuray, Inc.
|
$100.9M | -$0.11 | -1.19% | -296.83% | $2.53 |
|
ATEC
Alphatec Holdings, Inc.
|
$212.2M | $0.04 | 17.11% | -88.21% | $24.62 |
|
BSX
Boston Scientific Corp.
|
$5.3B | $0.78 | 11.3% | 75.74% | $104.75 |
|
PSTV
Plus Therapeutics, Inc.
|
$1.2M | -$0.04 | 22.78% | -97.49% | $5.50 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LNMG
Linike Medical Group Ltd.
|
$0.0350 | -- | $121.6K | -- | $0.00 | 0% | 1.95x |
|
ABT
Abbott Laboratories
|
$116.35 | $133.39 | $202.3B | 31.30x | $0.63 | 2.06% | 4.59x |
|
ARAY
Accuray, Inc.
|
$0.58 | $2.53 | $68.6M | 149.00x | $0.00 | 0% | 0.15x |
|
ATEC
Alphatec Holdings, Inc.
|
$13.62 | $24.62 | $2B | -- | $0.00 | 0% | 2.67x |
|
BSX
Boston Scientific Corp.
|
$76.85 | $104.75 | $114B | 39.63x | $0.00 | 0% | 5.72x |
|
PSTV
Plus Therapeutics, Inc.
|
$0.30 | $5.50 | $41.6M | -- | $0.00 | 0% | 4.85x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LNMG
Linike Medical Group Ltd.
|
-- | 5.621 | -- | -- |
|
ABT
Abbott Laboratories
|
21.33% | 0.218 | 6.97% | 1.05x |
|
ARAY
Accuray, Inc.
|
76.53% | 1.787 | 177.87% | 0.52x |
|
ATEC
Alphatec Holdings, Inc.
|
94.3% | 1.734 | 18.93% | 1.24x |
|
BSX
Boston Scientific Corp.
|
33.07% | 0.600 | 8.45% | 0.94x |
|
PSTV
Plus Therapeutics, Inc.
|
0.41% | -3.087 | 0.02% | 1.22x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LNMG
Linike Medical Group Ltd.
|
-- | -- | -- | -- | -- | -- |
|
ABT
Abbott Laboratories
|
$6.1B | $2.4B | 10.13% | 12.91% | 20.68% | $2.6B |
|
ARAY
Accuray, Inc.
|
$24.1M | -$5.5M | -14.23% | -60.6% | -5.37% | -$21.6M |
|
ATEC
Alphatec Holdings, Inc.
|
$130.4M | -$5.4M | -23.65% | -1092.5% | -2.52% | $5.7M |
|
BSX
Boston Scientific Corp.
|
$3.6B | $1.2B | 8.3% | 12.55% | 22.93% | $1B |
|
PSTV
Plus Therapeutics, Inc.
|
$1.3M | -$4.5M | -- | -- | -320.83% | -$2.6M |
Linike Medical Group Ltd. vs. Competitors
-
Which has Higher Returns LNMG or ABT?
Abbott Laboratories has a net margin of -- compared to Linike Medical Group Ltd.'s net margin of 15.71%. Linike Medical Group Ltd.'s return on equity of -- beat Abbott Laboratories's return on equity of 12.91%.
Company Gross Margin Earnings Per Share Invested Capital LNMGLinike Medical Group Ltd.-- -- -- ABTAbbott Laboratories53.5% $1.03 $66.9B -
What do Analysts Say About LNMG or ABT?
Linike Medical Group Ltd. has a consensus price target of --, signalling upside risk potential of 98674.37%. On the other hand Abbott Laboratories has an analysts' consensus of $133.39 which suggests that it could grow by 14.65%. Given that Linike Medical Group Ltd. has higher upside potential than Abbott Laboratories, analysts believe Linike Medical Group Ltd. is more attractive than Abbott Laboratories.
Company Buy Ratings Hold Ratings Sell Ratings LNMGLinike Medical Group Ltd.0 0 0 ABTAbbott Laboratories16 7 0 -
Is LNMG or ABT More Risky?
Linike Medical Group Ltd. has a beta of -6.348, which suggesting that the stock is 734.788% less volatile than S&P 500. In comparison Abbott Laboratories has a beta of 0.741, suggesting its less volatile than the S&P 500 by 25.919%.
-
Which is a Better Dividend Stock LNMG or ABT?
Linike Medical Group Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Abbott Laboratories offers a yield of 2.06% to investors and pays a quarterly dividend of $0.63 per share. Linike Medical Group Ltd. pays -- of its earnings as a dividend. Abbott Laboratories pays out 64.54% of its earnings as a dividend. Abbott Laboratories's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios LNMG or ABT?
Linike Medical Group Ltd. quarterly revenues are --, which are smaller than Abbott Laboratories quarterly revenues of $11.5B. Linike Medical Group Ltd.'s net income of -- is lower than Abbott Laboratories's net income of $1.8B. Notably, Linike Medical Group Ltd.'s price-to-earnings ratio is -- while Abbott Laboratories's PE ratio is 31.30x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Linike Medical Group Ltd. is 1.95x versus 4.59x for Abbott Laboratories. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LNMGLinike Medical Group Ltd.1.95x -- -- -- ABTAbbott Laboratories4.59x 31.30x $11.5B $1.8B
-
Which has Higher Returns LNMG or ARAY?
Accuray, Inc. has a net margin of -- compared to Linike Medical Group Ltd.'s net margin of -13.47%. Linike Medical Group Ltd.'s return on equity of -- beat Accuray, Inc.'s return on equity of -60.6%.
Company Gross Margin Earnings Per Share Invested Capital LNMGLinike Medical Group Ltd.-- -- -- ARAYAccuray, Inc.23.54% -$0.11 $227.6M -
What do Analysts Say About LNMG or ARAY?
Linike Medical Group Ltd. has a consensus price target of --, signalling upside risk potential of 98674.37%. On the other hand Accuray, Inc. has an analysts' consensus of $2.53 which suggests that it could grow by 337.23%. Given that Linike Medical Group Ltd. has higher upside potential than Accuray, Inc., analysts believe Linike Medical Group Ltd. is more attractive than Accuray, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LNMGLinike Medical Group Ltd.0 0 0 ARAYAccuray, Inc.2 0 0 -
Is LNMG or ARAY More Risky?
Linike Medical Group Ltd. has a beta of -6.348, which suggesting that the stock is 734.788% less volatile than S&P 500. In comparison Accuray, Inc. has a beta of 1.192, suggesting its more volatile than the S&P 500 by 19.162%.
-
Which is a Better Dividend Stock LNMG or ARAY?
Linike Medical Group Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Accuray, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Linike Medical Group Ltd. pays -- of its earnings as a dividend. Accuray, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LNMG or ARAY?
Linike Medical Group Ltd. quarterly revenues are --, which are smaller than Accuray, Inc. quarterly revenues of $102.2M. Linike Medical Group Ltd.'s net income of -- is lower than Accuray, Inc.'s net income of -$13.8M. Notably, Linike Medical Group Ltd.'s price-to-earnings ratio is -- while Accuray, Inc.'s PE ratio is 149.00x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Linike Medical Group Ltd. is 1.95x versus 0.15x for Accuray, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LNMGLinike Medical Group Ltd.1.95x -- -- -- ARAYAccuray, Inc.0.15x 149.00x $102.2M -$13.8M
-
Which has Higher Returns LNMG or ATEC?
Alphatec Holdings, Inc. has a net margin of -- compared to Linike Medical Group Ltd.'s net margin of -10.21%. Linike Medical Group Ltd.'s return on equity of -- beat Alphatec Holdings, Inc.'s return on equity of -1092.5%.
Company Gross Margin Earnings Per Share Invested Capital LNMGLinike Medical Group Ltd.-- -- -- ATECAlphatec Holdings, Inc.61.24% -$0.14 $632.1M -
What do Analysts Say About LNMG or ATEC?
Linike Medical Group Ltd. has a consensus price target of --, signalling upside risk potential of 98674.37%. On the other hand Alphatec Holdings, Inc. has an analysts' consensus of $24.62 which suggests that it could grow by 80.73%. Given that Linike Medical Group Ltd. has higher upside potential than Alphatec Holdings, Inc., analysts believe Linike Medical Group Ltd. is more attractive than Alphatec Holdings, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LNMGLinike Medical Group Ltd.0 0 0 ATECAlphatec Holdings, Inc.8 1 0 -
Is LNMG or ATEC More Risky?
Linike Medical Group Ltd. has a beta of -6.348, which suggesting that the stock is 734.788% less volatile than S&P 500. In comparison Alphatec Holdings, Inc. has a beta of 1.020, suggesting its more volatile than the S&P 500 by 1.994%.
-
Which is a Better Dividend Stock LNMG or ATEC?
Linike Medical Group Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alphatec Holdings, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Linike Medical Group Ltd. pays -- of its earnings as a dividend. Alphatec Holdings, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LNMG or ATEC?
Linike Medical Group Ltd. quarterly revenues are --, which are smaller than Alphatec Holdings, Inc. quarterly revenues of $212.9M. Linike Medical Group Ltd.'s net income of -- is lower than Alphatec Holdings, Inc.'s net income of -$21.7M. Notably, Linike Medical Group Ltd.'s price-to-earnings ratio is -- while Alphatec Holdings, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Linike Medical Group Ltd. is 1.95x versus 2.67x for Alphatec Holdings, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LNMGLinike Medical Group Ltd.1.95x -- -- -- ATECAlphatec Holdings, Inc.2.67x -- $212.9M -$21.7M
-
Which has Higher Returns LNMG or BSX?
Boston Scientific Corp. has a net margin of -- compared to Linike Medical Group Ltd.'s net margin of 12.68%. Linike Medical Group Ltd.'s return on equity of -- beat Boston Scientific Corp.'s return on equity of 12.55%.
Company Gross Margin Earnings Per Share Invested Capital LNMGLinike Medical Group Ltd.-- -- -- BSXBoston Scientific Corp.68.5% $0.45 $36.4B -
What do Analysts Say About LNMG or BSX?
Linike Medical Group Ltd. has a consensus price target of --, signalling upside risk potential of 98674.37%. On the other hand Boston Scientific Corp. has an analysts' consensus of $104.75 which suggests that it could grow by 36.31%. Given that Linike Medical Group Ltd. has higher upside potential than Boston Scientific Corp., analysts believe Linike Medical Group Ltd. is more attractive than Boston Scientific Corp..
Company Buy Ratings Hold Ratings Sell Ratings LNMGLinike Medical Group Ltd.0 0 0 BSXBoston Scientific Corp.25 0 0 -
Is LNMG or BSX More Risky?
Linike Medical Group Ltd. has a beta of -6.348, which suggesting that the stock is 734.788% less volatile than S&P 500. In comparison Boston Scientific Corp. has a beta of 0.688, suggesting its less volatile than the S&P 500 by 31.155%.
-
Which is a Better Dividend Stock LNMG or BSX?
Linike Medical Group Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Boston Scientific Corp. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Linike Medical Group Ltd. pays -- of its earnings as a dividend. Boston Scientific Corp. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LNMG or BSX?
Linike Medical Group Ltd. quarterly revenues are --, which are smaller than Boston Scientific Corp. quarterly revenues of $5.3B. Linike Medical Group Ltd.'s net income of -- is lower than Boston Scientific Corp.'s net income of $670M. Notably, Linike Medical Group Ltd.'s price-to-earnings ratio is -- while Boston Scientific Corp.'s PE ratio is 39.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Linike Medical Group Ltd. is 1.95x versus 5.72x for Boston Scientific Corp.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LNMGLinike Medical Group Ltd.1.95x -- -- -- BSXBoston Scientific Corp.5.72x 39.63x $5.3B $670M
-
Which has Higher Returns LNMG or PSTV?
Plus Therapeutics, Inc. has a net margin of -- compared to Linike Medical Group Ltd.'s net margin of -316.61%. Linike Medical Group Ltd.'s return on equity of -- beat Plus Therapeutics, Inc.'s return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LNMGLinike Medical Group Ltd.-- -- -- PSTVPlus Therapeutics, Inc.93.84% -$0.04 $5.1M -
What do Analysts Say About LNMG or PSTV?
Linike Medical Group Ltd. has a consensus price target of --, signalling upside risk potential of 98674.37%. On the other hand Plus Therapeutics, Inc. has an analysts' consensus of $5.50 which suggests that it could grow by 1716.98%. Given that Linike Medical Group Ltd. has higher upside potential than Plus Therapeutics, Inc., analysts believe Linike Medical Group Ltd. is more attractive than Plus Therapeutics, Inc..
Company Buy Ratings Hold Ratings Sell Ratings LNMGLinike Medical Group Ltd.0 0 0 PSTVPlus Therapeutics, Inc.4 0 0 -
Is LNMG or PSTV More Risky?
Linike Medical Group Ltd. has a beta of -6.348, which suggesting that the stock is 734.788% less volatile than S&P 500. In comparison Plus Therapeutics, Inc. has a beta of 0.788, suggesting its less volatile than the S&P 500 by 21.173%.
-
Which is a Better Dividend Stock LNMG or PSTV?
Linike Medical Group Ltd. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Plus Therapeutics, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Linike Medical Group Ltd. pays -- of its earnings as a dividend. Plus Therapeutics, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LNMG or PSTV?
Linike Medical Group Ltd. quarterly revenues are --, which are smaller than Plus Therapeutics, Inc. quarterly revenues of $1.4M. Linike Medical Group Ltd.'s net income of -- is lower than Plus Therapeutics, Inc.'s net income of -$4.4M. Notably, Linike Medical Group Ltd.'s price-to-earnings ratio is -- while Plus Therapeutics, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Linike Medical Group Ltd. is 1.95x versus 4.85x for Plus Therapeutics, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LNMGLinike Medical Group Ltd.1.95x -- -- -- PSTVPlus Therapeutics, Inc.4.85x -- $1.4M -$4.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will AI Disrupt SaaS Software Stocks?
Since January 28th, software stocks in the United States have…
Why Is Meta Stock Going Higher?
Over the last five days, shares of Instagram and Facebook…
Stock Ideas
Sell
47
Is NVDA Stock a Buy?
Market Cap: $4.3T
P/E Ratio: 36x
Sell
48
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 35x
Sell
40
Is GOOGL Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 29x
Alerts
Buy
54
AAOI alert for Mar 2
Applied Optoelectronics, Inc. [AAOI] is up 21.71% over the past day.
Buy
90
BNAI alert for Mar 2
Brand Engagement Network, Inc. [BNAI] is up 2.44% over the past day.
Sell
36
WLDN alert for Mar 2
Willdan Group, Inc. [WLDN] is down 1.93% over the past day.
